167 related articles for article (PubMed ID: 11711867)
21. NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder.
Toro C; Deakin JF
Schizophr Res; 2005 Dec; 80(2-3):323-30. PubMed ID: 16140506
[TBL] [Abstract][Full Text] [Related]
22. Changes in presynaptic proteins, SNAP-25 and synaptophysin, in the hippocampal CA1 area in ischemic gerbils.
Ishimaru H; Casamenti F; Uéda K; Maruyama Y; Pepeu G
Brain Res; 2001 Jun; 903(1-2):94-101. PubMed ID: 11382392
[TBL] [Abstract][Full Text] [Related]
23. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.
Sawada K; Barr AM; Nakamura M; Arima K; Young CE; Dwork AJ; Falkai P; Phillips AG; Honer WG
Arch Gen Psychiatry; 2005 Mar; 62(3):263-72. PubMed ID: 15753239
[TBL] [Abstract][Full Text] [Related]
24. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL
Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421
[TBL] [Abstract][Full Text] [Related]
25. SNAP-25 genotype influences NAA/Cho in left hippocampus.
Scherk H; Backens M; Zill P; Schneider-Axmann T; Wobrock T; Usher J; Reith W; Falkai P; Möller HJ; Bondy B; Gruber O
J Neural Transm (Vienna); 2008 Nov; 115(11):1513-8. PubMed ID: 18726138
[TBL] [Abstract][Full Text] [Related]
26. Neural stem cell proliferation is decreased in schizophrenia, but not in depression.
Reif A; Fritzen S; Finger M; Strobel A; Lauer M; Schmitt A; Lesch KP
Mol Psychiatry; 2006 May; 11(5):514-22. PubMed ID: 16415915
[TBL] [Abstract][Full Text] [Related]
27. Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia.
Burnet PW; Harrison PJ
Biol Psychiatry; 2000 Jan; 47(1):80-3. PubMed ID: 10650452
[TBL] [Abstract][Full Text] [Related]
28. CSF SNAP-25 in schizophrenia and bipolar illness. A pilot study.
Thompson PM; Rosenberger C; Qualls C
Neuropsychopharmacology; 1999 Dec; 21(6):717-22. PubMed ID: 10633477
[TBL] [Abstract][Full Text] [Related]
29. Deficits in axon-associated proteins in prefrontal white matter in bipolar disorder but not schizophrenia.
Shao L; Golbaz K; Honer WG; Beasley CL
Bipolar Disord; 2016 Jun; 18(4):342-51. PubMed ID: 27218831
[TBL] [Abstract][Full Text] [Related]
30. Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder.
Scarr E; Gray L; Keriakous D; Robinson PJ; Dean B
Bipolar Disord; 2006 Apr; 8(2):133-43. PubMed ID: 16542183
[TBL] [Abstract][Full Text] [Related]
31. The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations.
Oyler GA; Higgins GA; Hart RA; Battenberg E; Billingsley M; Bloom FE; Wilson MC
J Cell Biol; 1989 Dec; 109(6 Pt 1):3039-52. PubMed ID: 2592413
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in mice.
Ozdemir H; Ertugrul A; Basar K; Saka E
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):62-8. PubMed ID: 22640753
[TBL] [Abstract][Full Text] [Related]
33. Increased hippocampal supragranular Timm staining in subjects with bipolar disorder.
Dowlatshahi D; MacQueen G; Wang JF; Chen B; Young LT
Neuroreport; 2000 Nov; 11(17):3775-8. PubMed ID: 11117489
[TBL] [Abstract][Full Text] [Related]
34. Altered levels of Reelin and its isoforms in schizophrenia and mood disorders.
Fatemi SH; Kroll JL; Stary JM
Neuroreport; 2001 Oct; 12(15):3209-15. PubMed ID: 11711858
[TBL] [Abstract][Full Text] [Related]
35. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
Pantazopoulos H; Stone D; Walsh J; Benes FM
Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
[TBL] [Abstract][Full Text] [Related]
36. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia.
Honer WG; Falkai P; Young C; Wang T; Xie J; Bonner J; Hu L; Boulianne GL; Luo Z; Trimble WS
Neuroscience; 1997 May; 78(1):99-110. PubMed ID: 9135092
[TBL] [Abstract][Full Text] [Related]
37. Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics.
Marx CE; Stevens RD; Shampine LJ; Uzunova V; Trost WT; Butterfield MI; Massing MW; Hamer RM; Morrow AL; Lieberman JA
Neuropsychopharmacology; 2006 Jun; 31(6):1249-63. PubMed ID: 16319920
[TBL] [Abstract][Full Text] [Related]
38. Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness.
Honer WG; Falkai P; Bayer TA; Xie J; Hu L; Li HY; Arango V; Mann JJ; Dwork AJ; Trimble WS
Cereb Cortex; 2002 Apr; 12(4):349-56. PubMed ID: 11884350
[TBL] [Abstract][Full Text] [Related]
39. SNAP-25 deficit and hippocampal connectivity in schizophrenia.
Young CE; Arima K; Xie J; Hu L; Beach TG; Falkai P; Honer WG
Cereb Cortex; 1998; 8(3):261-8. PubMed ID: 9617921
[TBL] [Abstract][Full Text] [Related]
40. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness.
Che Y; Wang JF; Shao L; Young T
J Psychiatry Neurosci; 2010 Sep; 35(5):296-302. PubMed ID: 20569644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
